Clinical Trial Update: Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs

View source ↗

Summary

Oncoliq reports a clinical trial assessing early breast cancer detection using liquid biopsies and microRNA analysis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Oncoliq US Inc | Conditions: Breast Cancer Female, Breast Cancer | Status: RECRUITING